You are here: All Products  > AstraZeneca's Tagrisso Approved in China as First-Line Lung Cancer Treatment

AstraZeneca's Tagrisso Approved in China as First-Line Lung Cancer Treatment

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products